Maarten Bak

2.4k total citations · 1 hit paper
39 papers, 1.5k citations indexed

About

Maarten Bak is a scholar working on Psychiatry and Mental health, Clinical Psychology and Physiology. According to data from OpenAlex, Maarten Bak has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Psychiatry and Mental health, 10 papers in Clinical Psychology and 10 papers in Physiology. Recurrent topics in Maarten Bak's work include Schizophrenia research and treatment (23 papers), Diet and metabolism studies (9 papers) and Mental Health and Psychiatry (7 papers). Maarten Bak is often cited by papers focused on Schizophrenia research and treatment (23 papers), Diet and metabolism studies (9 papers) and Mental Health and Psychiatry (7 papers). Maarten Bak collaborates with scholars based in Netherlands, United Kingdom and United States. Maarten Bak's co-authors include Jim van Os, Marjan Drukker, Annemarie Fransen, Philippe Delespaul, Ron de Graaf, Inez Myin‐Germeys, Sinan Gülöksüz, Saskia van Dorsselaer, Wilma Vollebergh and Tineke Lataster and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Psychological Medicine.

In The Last Decade

Maarten Bak

37 papers receiving 1.4k citations

Hit Papers

Almost All Antipsychotics Result in Weight Gain: A Meta-A... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maarten Bak Netherlands 21 878 433 342 216 202 39 1.5k
Petter Andreas Ringen Norway 25 1.7k 2.0× 510 1.2× 217 0.6× 239 1.1× 183 0.9× 52 2.3k
James Robinson United States 22 898 1.0× 533 1.2× 132 0.4× 198 0.9× 234 1.2× 34 1.9k
Laila Asmal South Africa 23 1.2k 1.3× 491 1.1× 135 0.4× 315 1.5× 102 0.5× 87 1.7k
Carmen Simonsen Norway 23 1.6k 1.8× 561 1.3× 405 1.2× 284 1.3× 79 0.4× 76 2.2k
Olesya Ajnakina United Kingdom 21 1.0k 1.2× 480 1.1× 241 0.7× 341 1.6× 137 0.7× 55 1.9k
Gabriele Sachs Austria 18 645 0.7× 397 0.9× 353 1.0× 151 0.7× 59 0.3× 97 1.7k
José M. Rubio United States 23 947 1.1× 409 0.9× 218 0.6× 272 1.3× 57 0.3× 64 1.7k
Manuel Bousoño Spain 21 895 1.0× 612 1.4× 207 0.6× 114 0.5× 61 0.3× 61 1.6k
Piet Oosthuizen South Africa 24 1.0k 1.2× 800 1.8× 240 0.7× 267 1.2× 83 0.4× 39 1.7k
D. V. Jeste United States 22 1.5k 1.7× 441 1.0× 217 0.6× 387 1.8× 298 1.5× 30 2.2k

Countries citing papers authored by Maarten Bak

Since Specialization
Citations

This map shows the geographic impact of Maarten Bak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Bak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Bak more than expected).

Fields of papers citing papers by Maarten Bak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten Bak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Bak. The network helps show where Maarten Bak may publish in the future.

Co-authorship network of co-authors of Maarten Bak

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten Bak. A scholar is included among the top collaborators of Maarten Bak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten Bak. Maarten Bak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bak, Maarten, et al.. (2024). Glucagon‐like peptide agonists for weight management in antipsychotic‐induced weight gain: A systematic review and meta‐analysis. Acta Psychiatrica Scandinavica. 150(6). 516–529. 21 indexed citations
2.
Drukker, Marjan, et al.. (2024). Exploring the Consequences of Aggressive Experiences on Psychiatric Nurses: A Real‐Time Assessment Study. Perspectives In Psychiatric Care. 2024(1).
4.
Drukker, Marjan, et al.. (2023). Association between antipsychotic medication and clinically relevant weight change: meta-analysis. BJPsych Open. 9(1). e18–e18. 14 indexed citations
5.
Radhakrishnan, Rajiv, Lotta-Katrin Pries, Gamze Erzın, et al.. (2022). Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis. Psychological Medicine. 53(12). 5551–5557. 5 indexed citations
7.
Os, Jim van, Lotta-Katrin Pries, Margreet ten Have, et al.. (2021). Context v. algorithm: evidence that a transdiagnostic framework of contextual clinical characterization is of more clinical value than categorical diagnosis. Psychological Medicine. 53(5). 1825–1833. 12 indexed citations
8.
Drukker, Marjan, et al.. (2021). Development of a Methodological Quality Criteria List for Observational Studies: The Observational Study Quality Evaluation. SHILAP Revista de lepidopterología. 6. 675071–675071. 42 indexed citations
9.
Bak, Maarten, Chris Bervoets, Jürgen De Fruyt, et al.. (2019). The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis. European Psychiatry. 57. 78–100. 30 indexed citations
10.
Bak, Maarten, et al.. (2014). Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis. PLoS ONE. 9(4). e94112–e94112. 360 indexed citations breakdown →
11.
Nierop, Martine van, Tineke Lataster, Feikje Smeets, et al.. (2014). Psychopathological Mechanisms Linking Childhood Traumatic Experiences to Risk of Psychotic Symptoms: Analysis of a Large, Representative Population-Based Sample. Schizophrenia Bulletin. 40(Suppl_2). S123–S130. 92 indexed citations
12.
Bak, Maarten. (2012). Monitoring Clozapine Adverse Effects Calls for the Integration of Protocol and Good Clinical Practice. The Journal of Clinical Psychiatry. 73(10). 1313–1314. 7 indexed citations
13.
Drukker, Marjan, Jim van Os, Maarten Bak, Joost á Campo, & Philippe Delespaul. (2010). Systematic monitoring of needs for care and global outcomes in patients with severe mental illness. BMC Psychiatry. 10(1). 36–36. 17 indexed citations
14.
Lataster, Johan, Jim van Os, Lieuwe de Haan, et al.. (2010). Emotional Experience and Estimates of D2Receptor Occupancy in Psychotic Patients Treated With Haloperidol, Risperidone, or Olanzapine. The Journal of Clinical Psychiatry. 72(10). 1397–1404. 30 indexed citations
15.
Drukker, Marjan, Maarten Bak, Joost á Campo, et al.. (2009). The cumulative needs for care monitor: a unique monitoring system in the south of the Netherlands. Social Psychiatry and Psychiatric Epidemiology. 45(4). 475–485. 36 indexed citations
16.
Drukker, Marjan, et al.. (2007). [Can the "Camberwell Assessment of Need" predict changes in care consumption?].. PubMed. 49(5). 305–14. 5 indexed citations
17.
18.
Drukker, Marjan, et al.. (2007). The use of the Camberwell Assessment of Need in treatment: what unmet needs can be met?. Social Psychiatry and Psychiatric Epidemiology. 43(5). 410–417. 31 indexed citations
19.
Bak, Maarten, Inez Myin‐Germeys, Philippe Delespaul, et al.. (2005). Do different psychotic experiences differentially predict need for care in the general population?. Comprehensive Psychiatry. 46(3). 192–199. 55 indexed citations
20.
Krabbendam, Lydia, Inez Myin‐Germeys, M. Hanssen, et al.. (2004). Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation. Acta Psychiatrica Scandinavica. 110(4). 264–272. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026